Bruker Corporation (BRKR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bruker Corporation (BRKR) has a cash flow conversion efficiency ratio of 0.092x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($229.80 Million) by net assets ($2.51 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BRKR net asset quality index to measure how much of total assets are equity-financed.
Bruker Corporation - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Bruker Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Bruker Corporation cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Bruker Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bruker Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
eMemory Technology
TWO:3529
|
0.210x |
|
Motiva Infraestrutura de Mobilidade S.A.
SA:MOTV3
|
0.023x |
|
Jiangsu Leadmicro Nano Technology Co. Ltd. A
SHG:688147
|
N/A |
|
PrairieSky Royalty Ltd
TO:PSK
|
0.031x |
|
Samsung Engineering
KO:028050
|
-0.059x |
|
Inner Mongolia Dazhong Mining Co Ltd
SHE:001203
|
0.060x |
|
Yanzhou Coal Mining Company Limited
F:YZC
|
0.000x |
|
Vipshop Holdings Limited
F:1VPA
|
N/A |
Annual Cash Flow Conversion Efficiency for Bruker Corporation (1999–2025)
The table below shows the annual cash flow conversion efficiency of Bruker Corporation from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Bruker Corporation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $2.51 Billion | $134.10 Million | 0.053x | -61.41% |
| 2024-12-31 | $1.82 Billion | $251.30 Million | 0.138x | -44.11% |
| 2023-12-31 | $1.41 Billion | $350.10 Million | 0.248x | +7.01% |
| 2022-12-31 | $1.13 Billion | $262.00 Million | 0.231x | -11.08% |
| 2021-12-31 | $1.08 Billion | $282.40 Million | 0.260x | -23.88% |
| 2020-12-31 | $974.30 Million | $333.20 Million | 0.342x | +50.35% |
| 2019-12-31 | $938.20 Million | $213.40 Million | 0.227x | -14.11% |
| 2018-12-31 | $905.10 Million | $239.70 Million | 0.265x | +25.81% |
| 2017-12-31 | $733.50 Million | $154.40 Million | 0.210x | +11.54% |
| 2016-12-31 | $693.10 Million | $130.80 Million | 0.189x | -39.65% |
| 2015-12-31 | $732.90 Million | $229.20 Million | 0.313x | +111.14% |
| 2014-12-31 | $771.70 Million | $114.30 Million | 0.148x | -13.15% |
| 2013-12-31 | $850.20 Million | $145.00 Million | 0.171x | -9.08% |
| 2012-12-31 | $709.60 Million | $133.10 Million | 0.188x | +33.65% |
| 2011-12-31 | $624.90 Million | $87.70 Million | 0.140x | -52.58% |
| 2010-12-31 | $527.40 Million | $156.10 Million | 0.296x | -17.25% |
| 2009-12-31 | $418.80 Million | $149.80 Million | 0.358x | +4.63% |
| 2008-12-31 | $312.70 Million | $106.90 Million | 0.342x | +214.12% |
| 2007-12-31 | $259.20 Million | $28.21 Million | 0.109x | -44.65% |
| 2006-12-31 | $191.71 Million | $37.69 Million | 0.197x | -3.06% |
| 2005-12-31 | $208.03 Million | $42.19 Million | 0.203x | +5061.32% |
| 2004-12-31 | $217.47 Million | $-889.00K | -0.004x | +86.39% |
| 2003-12-31 | $202.55 Million | $-6.08 Million | -0.030x | +66.67% |
| 2002-12-31 | $126.38 Million | $-11.39 Million | -0.090x | -0.18% |
| 2001-12-31 | $127.55 Million | $-11.47 Million | -0.090x | -5430.38% |
| 2000-12-31 | $124.17 Million | $-202.00K | -0.002x | -100.30% |
| 1999-12-31 | $10.06 Million | $5.44 Million | 0.541x | -- |
About Bruker Corporation
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, ser… Read more